Application

17740988 · METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES

Filed 2022-05-10 · Granted · Patent 12122826 (2024-10-22) The official file ↗The patent and its PDF ↗ · Art unit 1649 · Examiner Christina M Borgeest Typical · CPC A61K 39/3955 · AbbVie Inc. · McCarter & English, LLP/Celgene & Abbvie

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

18.7 mo

to disposition 29.4 mo

Statutes raised

103 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.